Autoreactive T-cell responses: New technology in pursuit of an old nemesis

Pediatric Diabetes

Volumn 8, Issue 5, 2007, Pages 249-251

  Piganelli, Jon D ^a   Mathews, Clayton E ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CYTOKINE; GLUTAMATE DECARBOXYLASE 65; INSULIN; PANCREAS ISLET CELL ANTIBODY; PANCREAS ISLET CELL ANTIGEN 2; T LYMPHOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; AUTOIMMUNE DISEASE; CELL ASSAY; DIABETES MELLITUS; DISEASE PREDISPOSITION; EDITORIAL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; GENOTYPE; HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN MICROARRAY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TYPE 1A DIABETES MELLITUS;

AUTOANTIBODIES; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 1; HUMANS; INTERFERON TYPE II; INTERLEUKINS; ISLETS OF LANGERHANS; T-LYMPHOCYTES;

EID: 34548728078     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2007.00314.x     Document Type: Editorial

References (11)

1. Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974: 2: 1279-1283.
2. Pietropaolo M, Yu S, Libman IM et al. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies. Pediatr Diabetes 2005: 6: 184-192.
3. Riley WJ, Maclaren NK, Krischer J et al. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 1990: 323: 1167-1172.
4. Schatz D, Krischer J, Horne G et al. Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives. J Clin Invest 1994: 93: 2403-2407.
5. Pietropaolo M, Becker DJ, La Porte RE et al. Progression to insulin-requiring diabetes in seronegative prediabetic subjects: The role of two HLA-DQ high-risk haplotypes. Diabetologia 2002: 45: 66-76.
6. Wilson SB, Kent SC, Patton KT et al. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 1998: 391: 177-181.
7. Kotani R, Nagata M, Moriyama H et al. Detection of GAD65-reactive T-Cells in type 1 diabetes by immunoglobulin-free ELISPOT assays. Diabetes Care 2002: 25: 1390-1397.
8. Peakman M, Tree TI, Endl J, van Endert P, Atkinson MA, Roep BO. Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of autoreactive T-cells in type 1 diabetes: Report of phase II of the Second International Immunology of Diabetes Society Workshop for Standardization of T-cell assays in type 1 diabetes. Diabetes 2001: 50: 1749-1754.
9. Reijonen H, Mallone R, Heninger AK et al. GAD65-specific CD4+ T-cells with high antigen avidity are prevalent in peripheral blood of patients with type 1 diabetes. Diabetes 2004: 53: 1987-1994.
10. Roep BO, Atkinson MA, van Endert PM, Gottlieb PA, Wilson SB, Sachs JA. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays. J Autoimmun 1999: 13: 267-282.
11. Schloot NC, Meierhoff G, Karlsson Faresjo M et al. Comparison of cytokine ELISpot assay formats for the detection of islet antigen autoreactive T cells. Report of the third immunology of diabetes society T-cell workshop. J Autoimmun 2003: 21: 365-376.